Candida auris outbreak in healthcare facilities in ...
or interhospital transmission of C. auris have been published [12-14]. C. auris is a newly emerging yeast that was first described in 2009 after isolation from the ear canal of a Japanese patient [15], and has subsequently been associated with invasive infections and outbreaks in healthcare settings.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
SURVEILLANCE REPORT: Antimicrobial resistance …
www.ecdc.europa.euv SURVEILLANCE REPORT Antimicrobial resistance surveillance in Europe 2014 3.29. Streptococcus pneumoniae. Total number of tested isolates (N) and percentages non-susceptible to macrolides (%IR), including 95 % confidence intervals (95 % …
Report, Resistance, Surveillance, Antimicrobial, Europe, Antimicrobial resistance, Surveillance report, Surveillance report antimicrobial resistance surveillance in europe
TECHNICAL DOCUMENT - European Centre for Disease ...
www.ecdc.europa.euTECHNICAL DOCUMENT Social marketing guide for public health managers and practitioners 1 Summary The ECDC Social Marketing guide provides public health programme managers and practitioners with a summary of social marketing concepts and approaches.
Suspected adverse reactions to COVID-19 vaccination and ...
www.ecdc.europa.euDuring the same period, 354 177 (0.2%) cases of suspected adverse reactions after vaccination were reported to EudraVigilance [15] (Table 1). The vast majority of suspected adverse reaction reports so far relate to general reactions and the administration site (e.g. ‘flu-like’ illness, headache, pain at the application site, chills, fatigue,
Options for the use of rapid antigen tests for COVID-19 JD
www.ecdc.europa.euclinical validations of rapid antigen tests. Summary ... Timely and accurate COVID-19 testing is an essential part of surveillance, contact tracing, infection prevention and ... The EU regulatory framework for diagnostic tests Reagents, control materials, testing kits, and instruments intended for medical use are referred to as in vitro ...
Interim public Health considerations for COVID-19 ...
www.ecdc.europa.euvaccinating at least 80% of people over the age of 80 years and 80% of health and social care professionals in every Member State by March. In addition, a minimum of 70% of the adult (18 years and older) population were to be vaccinated by the summer [5]. EU/EEA countries initially prioritised vaccination of older adults, residents
Heating, ventilation and air-conditioning systems in the ...
www.ecdc.europa.eurequired air exchanges during customary use are proposed by the American Society of Heating Refrigerating and Air-Conditioning Engineers (ASHRAE) as 7-10 L/s per person [33] . The Federation of European H eating, Ventilation and Air Conditioning Associations (REHVA) recommends ensuring the minimum number of air
American, Society, Eating, Heating, Refrigerating, And air, American society of heating refrigerating and air, H eating
Implications of the emergence and spread of the SARS-CoV …
www.ecdc.europa.euTHREAT ASSESSMENT BRIEF Implications for the EU/EEA on the emergence and spread of the SARS-CoV-2 B.1.1.529 variant 3 Omicron properties The variant B.1.1.529 (Omicron) belongs to Pango lineage B.1.1.529, Nextstrain clade 21K [11], and is characterised by 30 amino acid changes, three small deletions and one small insertion in the spike protein
Threat assessment brief - Emergence of SARS-CoV-2 variant ...
www.ecdc.europa.euTHREAT ASSESSMENT BRIEF Implications for the EU/EEA on the spread of the SARS-CoV-2 B.1.1.529 variant – first update 3 across the region, but these are under investigation. The majority of confirmed cases have a history of travel to southern African countries, with some having taken connecting flights at other destinations between Africa and
Surveillance of antimicrobial resistance in Europe, 2020 data
www.ecdc.europa.euSince the adoption of the European Strategic Action Plan on Antibiotic Resistance in 2011 and the publication (1) of the Global Action Plan on Antimicrobial Resistance (GAP-AMR) in 2015 , most Member States of the WHO (2) European Region have enhanced efforts to tackle AMR. Only 25 (50%) of the 50 countries reported having devel-
Resistance, Action, Antimicrobial, Antimicrobial resistance, On antimicrobial resistance
CDTR Week 49, 5-11 December 2021
www.ecdc.europa.euEU Threats On 31 December 2019, the Wuhan Municipal Health and Health Commission reported a cluster of pneumonia cases of unknown aetiology with a common source of exposure at Wuhan's South China Seafood City market. Further investigations identified a novel coronavirus as the causative agent of respiratory symptoms for these cases.
Related documents
2022 renewable energy industry outlook
www2.deloitte.comTransmission projects, especially interregional, have so far remained a major challenge for renewable growth as they face difficulty in gaining regulatory approval from every state they cross, as well as refusal from landowners, and opposition from ... transmission projects to boost renewable energy access.
International Economics - Prexams
cdn.prexams.comlisher prior to any prohibited reproduction, storage in a retrieval system, or transmission in any form or by any means, electronic, mechanical, photocopying, recording, or likewise. To obtain permission(s) to use material from this work,